Sienna Biopharmaceuticals, Inc.
DelistedCIK 1656328fmd_06MNGZZ9BJCX34C20T8Y3RQ19GManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Sep 30, 2019, 16 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|
| Total revenues | – | – | – | 0 |
| Research and development | 2 | 11 | 30 | 52 |
| Total operating expenses | 11 | 21 | 49 | 76 |
| Operating income | (11) | (21) | (49) | (76) |
| Other non-operating income (expense) | (0) | (0) | (2) | 3 |
| Income before taxes | (11) | (21) | (51) | (73) |
| Income tax expense | – | – | (0) | – |
| Net income from continuing operations | – | – | (51) | – |
| Net income | (11) | (21) | (51) | (73) |